CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 27 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-28 | Lotvin Alan Director | Grant or award · Director stock option (right to buy) | +135,000 | 135,000 | ||
| 2026-05-28 | Jimenez Santos Jose Ignacio Director | Grant or award · Director stock option (right to buy) | +135,000 | 135,000 | ||
| 2026-05-28 | Fox Jennifer A. Director | Grant or award · Director stock option (right to buy) | +135,000 | 135,000 | ||
| 2026-05-28 | DOYLE WILLIAM F Director | Grant or award · Director stock option (right to buy) | +135,000 | 135,000 | ||
| 2026-05-28 | Sinha Uma Director | Grant or award · Director stock option (right to buy) | +135,000 | 135,000 | ||
| 2026-05-28 | Legorreta Pablo G. Director | Grant or award · Director stock option (right to buy) | +135,000 | 135,000 | ||
| 2026-05-28 | Pereira Brian JG Director | Grant or award · Director stock option (right to buy) | +135,000 | 135,000 | ||
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Conversion | +63,118,645 | 73,842,723 | ||
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Conversion · Class B Common Shares | −63,118,645 | 0 | ||
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Conversion · Common Units in ProKidney LLC | −63,118,645 | 0 | ||
| 2026-03-01 | Coulston James Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +600,000 | 600,000 | ||
| 2026-03-01 | Weber Darin J. Chief Regulatory Officer | Grant or award · Employee stock option (right to buy) | +400,000 | 400,000 | ||
| 2026-03-01 | Girolamo Todd C Chief Legal Officer | Grant or award · Employee stock option (right to buy) | +600,000 | 600,000 | ||
| 2026-03-01 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +3,000,000 | 3,000,000 | ||
| 2025-11-13 | Pereira Brian JG Director | Sale | −447,803 | $2.37 | $1.1M | 0 |
| 2025-11-13 | Pereira Brian JG Director | Sale | −54,333 | $2.37 | $129K | 0 |
| 2025-11-12 | Pereira Brian JG Director | Sale | −227,431 | $2.72 | $619K | 447,803 |
| 2025-11-12 | Pereira Brian JG Director | Sale | −27,595 | $2.72 | $75K | 54,333 |
| 2025-07-08 | Weber Darin J. Chief Regulatory Officer | Sale 10b5-1 | −103,480 | $3.02 | $313K | 0 |
| 2025-06-03 | Legorreta Pablo G. Director | Conversion | +3,823,996 | 26,441,905 |
Page 2 of 9 · 179 trades